![Tomaz Vaupotic, Senior Director, Head of Clinical & Medical Quality, Alvotech [NASDAQ: ALVO] | Life Sciences Review](https://www.lifesciencesrevieweurope.com/newstransfer/upload/450x308_xYni.jpg "Tomaz Vaupotic, Senior Director, Head of Clinical & Medical Quality, Alvotech [NASDAQ: ALVO] | Life Sciences Review")
![Martin Bostrup, Executive Director, Market Access & Medical Affairs, EMEA, Veracyte, Inc [NASDAQ: VCYT] | Life Sciences Review](https://www.lifesciencesrevieweurope.com/newstransfer/upload/99-450x308_3z5D.jpg "Martin Bostrup, Executive Director, Market Access & Medical Affairs, EMEA, Veracyte, Inc [NASDAQ: VCYT] | Life Sciences Review")
![Jesper Lekdorf, VP Global Medical Affairs, Novo Nordisk [CPH: NOVO-B] | Life Sciences Review](https://www.lifesciencesrevieweurope.com/newstransfer/upload/144-450x308_TWZ7.jpg)
Real-World Evidence Empowering Patient-Focused Medical Affairs
Jesper Lekdorf, VP Global Medical Affairs, Novo Nordisk [CPH: NOVO-B]
Inventus: Rethinking the Infrastructure Behind Clinical Trials
Jim Michel, Chairman; Steve Sanghera, Co-Founder and CEO
Adapt to New Trends to be Competitive
Brian Thoma, PhD; Director Service Solutions North America, QIAGEN
How Can We Tackle the Health Equity Gap to Innovative Medicines?
Silvy Mardiguian, PhD Market Access Director, UK & Ireland
Laboratori Baldacci S.p.A.: A Century of Medical Legacy, Built on Original Therapies
Marco Bertini, R&D and Medical Affairs Manager![Stefano Biondi, VP of Pre-Clinical, Recordati S.p.A [BIT: REC] | Life Sciences Review](https://www.lifesciencesrevieweurope.com/newstransfer/upload/Untitled-1-450x308_PCfA.jpg)
Navigating Through Drug Discovery and Development
Stefano Biondi, VP of Pre-Clinical, Recordati S.p.A [BIT: REC]
Clinical research in the UK: Increasing Inclusion, Accountability and Decreasing Waste.
Jenny RiversDirector of Research and DevelopmentBarts Health NHS Trust
Machine-Learning-Generated Insights from Health Data: Promise of Natural Language Processing
Kim WagerScientific DirectorOxford PharmaGenesis
Early Phase Biologics Characterization; a Key Factor for Risks Mitigation in Biologics Product Developments
Rafael Sande, Head Operations Characterization Large Molecule / Cell- and Gene Therapy Services at Solvias AG
EVis Bioscience: Advancing RNA Therapies through Smarter Biological Engineering
Elita Montanari, Co-Founder and CTO
The Tipping Point for Scalable Manufacturing Processes to Pivot Gene Therapies
Dr Linda Randall, AVP Biologics Development, Manufacturing & Control, Pharmaron
Cell and Gene Therapy Navigating the Next Frontier in Biomanufacturing
Narayana Rao, Senior Vice President, Global Bioprocessing Commercial, Avantor
The Importance of Incorporating Decentralised Clinical Trials (DCTS) and Patient Centricity by Design in Rare Disease Studies
Marcelo Vaz, Vice President, Medical Services, TMC Pharma Services Ltd
Cardialysis: Integrating Scientific Insight with Cardiovascular Trial Execution
Dr. Ernest Spitzer, CEO and Medical Director
